Insight Molecular Diagnostics Inc. (IMDX) Form 8-K — Jun 17, 2026
$IMDXForm 8-KItems 5.02, 5.07, 9.01Filed Jun 17, 2026, 4:05 PM ET0001493152-26-029078Original filing
Insight Molecular Diagnostics Inc. held its 2026 Annual Meeting of Shareholders on June 11, 2026, where holders of 23,954,212 shares representing 74.19% of voting power were present. Shareholders elected all four director nominees—Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E.
Key figures
- Shares Present
- 23954212
- Voting Power Percentage
- 74.19%
- Total Incentive Plan Shares
- 5550000
- Incentive Plan Share Increase
- 1750000
Price after filing
1 day: +2.3%7 days: +1.1%30 days: -11.5%
Close on the filing date to close N calendar days later (from $5.32). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.